Ciofi degli Atti M - Search Results

1

Ciofi degli Atti M, Filia A, Revello MG, Buffolano W, Salmaso S. Ciofi degli Atti M, et al. Euro Surveill. 2004 Apr;9(4):19-21. Euro Surveill. 2004. PMID: 15192262

2

A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

Greco D, Salmaso S, Mastrantonio P, Giuliano M, Tozzi AE, Anemona A, Ciofi degli Atti ML, Giammanco A, Panei P, Blackwelder WC, Klein DL, Wassilak SG. Greco D, et al. Among authors: ciofi degli atti ml. N Engl J Med. 1996 Feb 8;334(6):341-8. doi: 10.1056/NEJM199602083340601. N Engl J Med. 1996. PMID: 8538704 Free article. Clinical Trial.

3

[Epidemiology of invasive infections with Haemophilus influenzae type b in the world and in Italy].

Tozzi AE, Panei P, Ciofi degli Atti M, Anemona A, Scuderi G, Salmaso S. Tozzi AE, et al. Among authors: ciofi degli atti m. Ann Ig. 1995 Jul-Aug;7(4):235-41. Ann Ig. 1995. PMID: 8679163 Italian.

4

Incidence of invasive Haemophilus influenzae type b disease in Italian children.

Tozzi AE, Salmaso S, Ciofi degli Atti ML, Panei P, Anemona A, Scuderi G, Wassilak SG. Tozzi AE, et al. Among authors: ciofi degli atti ml. Eur J Epidemiol. 1997 Jan;13(1):73-7. doi: 10.1023/a:1007320124502. Eur J Epidemiol. 1997. PMID: 9062783

5

Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines.

Tozzi AE, Ciofi degli Atti ML, Wassilak SG, Salmaso S, Panei P, Anemona A, Luzi S, Greco D. Tozzi AE, et al. Among authors: ciofi degli atti ml. Vaccine. 1998 Jan-Feb;16(2-3):320-2. doi: 10.1016/s0264-410x(97)00163-1. Vaccine. 1998. PMID: 9607049 Clinical Trial.

6

Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.

Salmaso S, Mastrantonio P, Wassilak SG, Giuliano M, Anemona A, Giammanco A, Tozzi AE, Ciofi degli Atti ML, Greco D. Salmaso S, et al. Among authors: ciofi degli atti ml. Vaccine. 1998 Aug;16(13):1270-5. doi: 10.1016/s0264-410x(98)00040-1. Vaccine. 1998. PMID: 9682390 Clinical Trial.

7

Repeat whole cell vaccinations should be avoided after hypotonic-hyporesponsive episodes.

Tozzi AE, Ciofi degli Atti ML, Salmaso S, Anemona A. Tozzi AE, et al. Among authors: ciofi degli atti ml. BMJ. 1998 Aug 29;317(7158):604. doi: 10.1136/bmj.317.7158.604a. BMJ. 1998. PMID: 9721136 Free PMC article. Clinical Trial. No abstract available.

8

Long-term efficacy of pertussis vaccines in Italy. PROPER Study Working Group.

Salmaso S, Anemona A, Mastrantonio P, Stefanelli P, Tozzi AE, Ciofi degli Atti ML. Salmaso S, et al. Among authors: ciofi degli atti ml. Dev Biol Stand. 1998;95:189-94. Dev Biol Stand. 1998. PMID: 9855431 Clinical Trial. No abstract available.

9

Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21-40 months of age.

Ciofi degli Atti M, Anemona A, Tozzi AE, Stefanelli P, Giammanco A, Salmaso S. Ciofi degli Atti M, et al. Vaccine. 1999 Apr 9;17(15-16):2030-5. doi: 10.1016/s0264-410x(98)00405-8. Vaccine. 1999. PMID: 10217603 Clinical Trial.

10

Observer bias in acellular pertussis vaccine trials.

Salmaso S, Tozzi AE, Ciofi degli Atti ML. Salmaso S, et al. Among authors: ciofi degli atti ml. Pediatrics. 1999 Oct;104(4 Pt 1):997-8. doi: 10.1542/peds.104.4.997. Pediatrics. 1999. PMID: 10532870 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters